SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " Portfolios " 24 found 🔀 AI-powered Shuffle
Marsh survey examines how health systems are managing capital, investment strategies
Health systems’ finances improved in 2026, but many organizations remain under enough pressure to keep tapping reserves, taking on debt, and turning to investment portfolios for financial flexibili | Forty-three percent of respondents report expecting to draw on reserves in 2026, up from 37% the year prior.
OAK Global launches multi-class MGA capacity unit at Lloyd’s
OAK Partnerships will write property, specialty, credit and casualty portfolios through Syndicate 1440 from 2027
Inside Broward County’s battle for health care real estate
Broward County’s health care giants are racing to snap up real estate, competing for space amid rapid population growth and development. The county’s health care map, long dominated by a neatly defined duopoly between taxpayer funded hospital districts Broward Health and Memorial Healthcare System, is changing as an outpatient construction boom floods the market with new facilities and health care systems look beyond traditional medical real estate to expand their portfolios. But with prime development sites growing scarce, the county has emerged as a medical development battleground, with systems jockeying for land, market share and the opportunity to redraw the […]
Broker facilities expand as technology, alternative capital reshape placements
Broker facilities that automatically or rapidly provide following capacity are expanding as brokers seek to speed placements, use data to package portfolios of risks and tap additional sources of…
How financial advisors keep doomers from blowing up their portfolios
We're in a golden age for apocalyptic thinking, but that doesn't mean you should invest like we're near the end.
Huang says 1 number in the AI debate isn't science-based at all
Nvidia's CEO took aim at a figure that has shaped careers and portfolios, and the man behind it has his own doubts.
Fastly Inc. (FSLY) Jumps 15% Ahead of Tuesday’s Key Business Updates; Hedge Fund Conviction Weak
Fastly Inc. (NASDAQ:FSLY) climbed by 14.92 percent on Monday to end at $27.42 apiece as investors began positioning portfolios ahead of key business updates at its Investor Day meeting tomorrow, September 22. The rally was supported by earlier warnings from Anthropic Chief Executive Officer Dario Amodei that development of artificial intelligence must slow down and […]
Trump says he plans to remove a 15% tariff on Irish whiskey
The Irish Whiskey Association had called for the tariffs to be removed, arguing that such a step would help many U.S. companies with Irish products in their portfolios.
Milliman Acquires Blue Water MSR Valuation, Hedging Business
Milliman has acquired Blue Water’s mortgage servicing rights valuation and hedging services from Apex Analytics Corp., extending a wave of mortgage industry investment beyond servicing portfolios themselves to the technology and expertise used to manage their value.The transaction adds Blue Water’s MSR hedging platform, customer base, trading professionals, and quantitative analytics team to Milliman’s mortgage solutions practice. Financial terms were not disclosed.
New PENN Entertainment (PENN) Casino Set to Launch, Shares Jump Higher
PENN Entertainment Inc. (NASDAQ:PENN) is one of the 10 Stocks Surviving Market Slaughter. PENN Entertainment saw its share prices jump by 5.56 percent on Wednesday to close at $21.45 apiece, as investors positioned their portfolios ahead of the launch of a $360 million casino and hotel development in Illinois. In line with the closing of […]
Alignment Healthcare (ALHC) Climbs 7% Ahead of Business Updates
Alignment Healthcare Inc. (NASDAQ:ALHC) is one of the 10 Stocks With Stunning Gains. Alignment Healthcare bounced back by 7.11 percent on Tuesday to finish at $18.38 apiece, as investors positioned portfolios ahead of business updates from its participation in a health conference this week, while digesting changes in its leadership composition. In a notice on […]
Intel (INTC) Soars to All-Time High Ahead of Business Updates
Intel Corp. (NASDAQ:INTC) is one of the 10 Stocks Turning Heads With Double-Digit Gains. Intel Corp. climbed to a fresh all-time high on Tuesday as investors began positioning portfolios ahead of the upcoming participation of its chief executive officer (CEO), Lip-Bu Tan, in a technology conference this month. In an updated report, Intel Corp. (NASDAQ:INTC) […]
Global Health & WASH: May 2026 Funding Opportunities (14 new opportunities!)
The May update for Global Health & WASH brings new calls that cluster around three distinct shifts: LMIC research leadership moving from funder encouragement into a hard eligibility constraint, pharmaceutical and corporate-linked funders running structurally independent education and use-inspired research portfolios at substantial scale, and AI adoption shifting decisively from speculative tool to operational capability across health and WASH systems alike. In LMIC Research Leadership as Eligibility, Not Encouragement, Wellcome anchors the dominant signal of the month with three separate major calls that all require or strongly center LMIC leadership in their basic eligibility architecture. Wellcome’s ESIC Hubs (£1.5-£1.9M per hub over 3-5 years) explicitly requires an LMIC-based lead applicant, treating Global South leadership as a design constraint rather than a participation goal. Wellcome’s Infectious Disease Clinical Trial Development Award funds transdisciplinary teams whose lead must be a mid-career or established researcher based at an organization in Africa, South Asia, or Southeast Asia. Wellcome’s larger Infectious Disease Clinical Trial Award (£1M-£8M for optimizing licensed interventions) requires the administering organization to be in eligible LMIC regions and at least 50% of applicants based there. Around Wellcome, the same pattern shows up at smaller scale and across funders: CHINNOVA channels $1M into West and Central African research institutions for climate-health work; IBRO’s Neuroscience Training Grants explicitly tier ceilings by region of residence with Africa receiving the highest amount ($5,000); IHME’s GBD Emerging Researcher Award reserves at least one of its two annual awards for an LMIC researcher; Sidaction’s HIV Cure call funds research teams across France, the Netherlands, and eligible African countries with a minimum two-country collaboration requirement. Taken together, these calls signal a meaningful shift in how research equity is being operationalized — not as encouragement language at the bottom of a call, but as a structural feature of who can lead, where the work must be administered, and what proportion of the team must be regionally rooted. In Pharma-Funded Independent Medical Education and Use-Inspired Research, the lineup this month is unusually deep. Pfizer alone runs four parallel calls under independent education and quality improvement frameworks: a Migraine and Women’s Health RFP (200K x 2-year, $500K pool), Migraine IME ($200K, $1M pool), JAK Inhibitor evidence-based education ($100K), and Maternal Vaccination HCP Education in Saudi Arabia ($75K), plus a separate Pediatric Pneumococcal Surveillance research call in Saudi Arabia ($400K per project). Novo Nordisk Foundation runs four parallel calls of its own at substantial scale: Infectious Diseases Catalyst Grants (DKK 60M pool, up to DKK 7M collaborative), Non-Diabetic Endocrinology Collaborative Grants (DKK 53M pool, DKK 5-10M per project), Pioneer Innovator Grant Health (DKK 1.1M), and Distinguished Innovator Grant Health (DKK 6.8M). LEO Foundation deploys DKK 2-4M per project for dermatology research excellence. Pfizer’s framing across calls deliberately separates the funding from product promotion, emphasizing measurable practice-relevant change and structural distance between scientific outputs and commercial activity. Novo Nordisk’s “use-inspired” hard filter pushes researchers toward a credible translation pathway from mechanism to deployable tool. The pattern: industry-aligned funders are running structurally independent portfolios at meaningful $ that fund implementation evidence, not promotion. In AI as Operational Capability, Not Speculation, several calls this month explicitly treat AI adoption as a near-term operational question with real evidence and governance requirements, rather than a speculative trend to be watched. Wellcome’s ESIC Hubs frames AI as “the accelerator” for evidence synthesis, asking hubs to translate technical innovation into adoption-ready workflows that can match real-world policy timelines. UNICEF Venture Fund’s new Climate Tech for Children’s Health call funds for-profit startups deploying AI, machine learning, and blockchain in low-resource environments, with a strict requirement that solutions must already have a working prototype with promising pilot results. The Water Research Foundation has launched two simultaneous AI calls treating reproducibility, cybersecurity guardrails, and human-in-the-loop deployments as core design constraints rather than nice-to-haves: one on GenAI and Agentic AI in water utilities ($200K), one on alternatives to water shutoffs that explicitly screens for implementation economics evidence. Nordic Innovation’s quantum technology call (NOK 4.5M) extends the same logic into life science and healthcare, demanding consortium-stage projects mature enough to test with real users. TEF-Health offers €300K in subsidized testing infrastructure for European healthcare AI and robotics SMEs. The pattern: funders are converting AI pilots into playbooks, requiring transfer evidence and risk controls before AI can move from experimentation to sector-wide operational practice. For LMIC-based researchers in infectious disease or evidence synthesis, the three Wellcome calls together represent the deepest concentration of LMIC-led research capital in recent memory — pair the Infectious Disease Clinical Trial Development Award (£200K, deadline May 19) as a strategic pipeline feeder into the larger Infectious Disease Clinical Trial Award (£1-£8M, deadline June 2), since the development award functions explicitly as a track into the larger trial scheme. For Nordic researchers, the four Novo Nordisk Foundation calls plus LEO Foundation and Nordic Innovation Quantum represent ~$30M in regional research capital this cycle, all with deadlines clustered in May-August. For WASH practitioners, the three Water Research Foundation calls together (each up to $200K) are a cluster worth reading across — one on AI deployment, one on shutoff alternatives, one rewarding applied innovation — and the strongest applicants will articulate how their work bridges utility operations to policy-relevant evidence. For US-based clinical researchers and educators, the four Pfizer calls plus the APF Portfolio’s 80+ programs form an unusually accessible recurring pipeline; APF’s prohibition on indirect costs is a meaningful structural feature for early-career applicants whose institutions might otherwise absorb significant overhead. Snapshot of New Opportunities Total Estimated Funding Pool: $100 Million+ USD The grants are organized into three categories: Open Calls: Current grant and opportunities with a deadline. Grants are listed by closing date. 39 open opportunities- 14 new! Rolling Applications: current grant and opportunities with rolling applications (but it’s still best to submit as early as possible). 14 rolling opportunities- 1 new opportunity! Long term planning: Grants that have closed their current rounds, but are expected to open new windows. 4 long term opportunities! A quick tip for returning readers: if you want to jump straight to the newest additions, use CTRL F to search for “New!” and navigate quickly to the latest funding opportunities This post is for paid subscribers. This helps support the time and effort it takes to curate and organize these opportunities. Subscribe To keep this accessible to everyone who needs it, we’re happy to offer pay what you can rates. You can find more details here. Open Calls: Migraine Competitive Grant Program: Migraine and Women’s Health (Quality Improvement and/or Research RFP), Pfizer.*Closing soon!* Pfizer, in collaboration with the American Headache Society, is seeking independent quality improvement and research projects that close persistent gaps in migraine care for women across the United States. The funding logic centers on measurable, practice-relevant change: proposals should generate actionable evidence, tools, or system improvements that can be shared and used widely, not just within a single site. Priority areas span menstrual migraine and screening in women’s health settings, the role of hormonal fluctuations across the lifespan, sex-specific risk factors, comorbidities and quality-of-life burden, and disparities in outcomes by race, ethnicity, and socioeconomic status. The call is structured as a two-step competitive process with an initial Letter of Intent, with the strongest concepts expected to translate scientific insight into implementable improvements in diagnosis, management, and equity. Geographies: United States. Who can apply: U.S.-based organizations (not individuals), including professional schools, healthcare institutions, professional organizations, and other entities focused on healthcare improvement. Funding amount: Up to USD $200,000 total over 2 years; total pool USD $500,000. Targeted Sectors / SDGs: Health; Focus areas: migraine, women’s health, quality improvement, clinical research, menstrual migraine, health disparities. Deadline: LOI: May 5, 2026; Full proposal (by invitation): August 28, 2026. Learn more and apply here. This RFP rewards “shareable impact”: the most competitive submissions will pair rigorous methods with a clear plan for system uptake and dissemination beyond the originating institution. ReSSARC: Strengthening the Health Sector and Food Security in the Central African Republic (AID 013381/01/0) Call for Proposals, Italian Agency for Development Cooperation (AICS). *Closing soon!* AICS is seeking a limited set of high-capacity humanitarian partners to deliver an integrated package that stabilizes essential health services while reducing acute malnutrition and strengthening food security resilience in priority areas of the Central African Republic. The funder’s logic is explicitly nexus-based: proposals should meet urgent, life-saving needs while reinforcing local systems, coordination mechanisms, and community-level capacity so results persist beyond the emergency window. AICS emphasizes inclusion and protection outcomes, expecting gender-sensitive design and explicit measures for groups facing compounded vulnerability, including women, children under five, internally displaced people, and people with disabilities. The call also signals a localization pathway, encouraging stronger collaboration with national NGOs and balanced partnerships, alongside clear coordination with existing cluster and humanitarian actors to minimize duplication and improve coverage. Geographies: Central African Republic (Bangui, Ombella-Mpoko, Ouham, Ouham-Pende, Lim-Pende, Lobaye). Who can apply: Non-profit organizations registered with AICS, plus eligible non-profits without an office in Italy that have a pre-existing collaboration agreement with an AICS-listed organization. Funding amount: Total pool EUR €1,800,000; max EUR €800,000 (single applicant) or EUR €1,000,000 (ATS). Targeted Sectors / SDGs: Health; Focus areas: malnutrition prevention and treatment, maternal and child health, community health services, food security and resilience, localization partnerships Deadline: May 5, 2026. Learn more and apply here. This call is structured to reward partners who can link frontline service delivery to system durability and localization, not just short-term coverage gains. Contracts for Innovation in drug and alcohol addiction healthcare, Innovate UK. *Closing soon!* Innovate UK, on behalf of the Office for Life Sciences Addiction Healthcare Goals program, is procuring R&D to accelerate innovations that can improve treatment outcomes, strengthen recovery, and reduce harm and deaths linked to drug and alcohol addiction. The competition is positioned as a market-facing readiness push: selected projects are expected to advance solutions toward later-stage validation, generate evidence of user acceptability and UK market fit, and map credible routes through regulatory and certification requirements. Innovate UK signals a preference for innovations that can be field-tested in relevant UK settings and progressed to TRL 6 or 7, with practical plans for commercialization after contract completion. This structure favors applicants that can execute most work in-house, co-develop with service providers and people with lived experience, and translate technical progress into deployable tools for addiction healthcare delivery. Geographies: United Kingdom. Who can apply: Single organizations of any size (including EU, EEA, or international) leading delivery, with most work and key deliverables carried out in the UK; subcontractors for specialist skills only. Funding amount: GBP £200,000–1.5 million per project (inclusive of VAT); Total pool: GBP £20 million (across two strands). Targeted Sectors / SDGs: Health; Focus areas: Mental Health, Health Systems Strengthening, Research & Development, Technology Access. Deadline: May 6, 2026 (11:00am). Learn more and apply here. This call uses procurement to pull near-market addiction innovations toward operational proof and adoption pathways in UK services.
From politics to portfolios: the market impact of rising populism
Populism has become part of the global landscape, rooted in frustrations over inequality, stagnant mobility, and a sense that mainstream policymakers have failed to adapt to shifting economic realities.
Plug Power (PLUG) Climbs 11.6% Ahead of Next Week’s Business Update
Plug Power Inc. (NASDAQ:PLUG) is one of the 10 Stocks With Unexpected Gains. Plug Power saw its share prices jump by 11.62 percent on Monday to close at $2.69 apiece, as investors loaded portfolios ahead of expected business updates next week. This after the company said that its newly installed Chief Executive Officer (CEO), Jose […]
2026 Perspectives in Private Equity: Sports
Professional sports continue to emerge as an attractive asset class for private equity investors, as evolving ownership dynamics, attractive fundamentals and underlying growth drivers create opportunities. Sports investments offer sponsors an opportunity to diversify portfolios, reduce risk and deliver uncorrelated returns, while tapping into an industry experiencing strong growth driven by continued demand for content, league expansion and the adoption of new revenue models. Sports teams and leagues can also represent unique trophy assets for investors, often delivering intangible value beyond financial returns.
Labels, Logistics And Legacy: The New Business Of Old French Wine Families
Centuries‑old French domaines are redesigning labels, reshaping portfolios and rethinking exports so the next generation can thrive in the international wine market.
How investors use the BRRRR strategy to scale real estate portfolios
"My strategy is basically to use every property to fund the next one," said one real estate investor.
Mattel to Acquire Full Ownership of Mattel163 Mobile Games Studio, Strengthening its Digital Games Business
EL SEGUNDO, Calif., February 10, 2026--Mattel, Inc. (Nasdaq: MAT), a leading global play and family entertainment company and owner of one of the most iconic brand portfolios in the world, today announced an agreement with its joint venture partner, NetEase, a leading internet and game services provider, to acquire full ownership of the Mattel163 mobile games studio. The transaction is expected to be completed by the end of Q1, subject to customary closing conditions.
Ryan Expands UK Business Rates and Property Tax Capabilities with Acquisition of WYM Rating
PLANO, Texas & EDINBURGH, Scotland, February 05, 2026--Ryan, a leading global tax services and software provider, is pleased to announce the acquisition of Williams Young McKaig Ltd, a specialized commercial property consultancy, and its specialist rating division, WYM Rating, based in Edinburgh. The acquisition establishes Ryan’s property tax and business rates presence in Scotland and expands the Firm’s ability to serve clients with complex commercial property portfolios across the United King
I talked to many health CEOs out West and see big things for drug stocks
Health care is going to resume its rightful place in big-time managers' portfolios.
Boston Scientific to acquire Penumbra for $14.5B
This is a cash and stock transaction that values Penumbra at $374 per share. The move helps Boston Scientific expand its vascular and neurovascular portfolios, gaining new treatments for pulmonary embolism, stroke, deep vein thrombosis and many other critical cardiovascular conditions.
Ondas Holdings (ONDS) Soars to All-Time High Ahead of Business Updates
We recently published Wall Street Can’t Keep up With These 10 Stocks on Fire. Ondas Holdings Inc. (NASDAQ:ONDS) was one of the top performers on Thursday. Ondas Holdings soared to a new all-time high on Thursday, as investors loaded portfolios in anticipation of positive announcements from a series of events next week. At intra-day trading, […]
Political power and profitable trades in the US Congress
The debate over whether US members of Congress should be allowed to trade individual stocks has become a mainstream policy concern. This column uses data on every US congressional stock trade from 1995 to 2021 to reveal that while rank-and-file members do not systematically beat the market, once some of them assume leadership positions their portfolios start to look very different and outperform those of regular members. The pattern raises uncomfortable questions about how political power, corporate access, and personal wealth interact.